(Q43883711)

27 November 2017

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity (English)

1 reference

27 November 2017

1 reference

4

Bart Barlogie

1 reference

27 November 2017

1

Shmuel Yaccoby

1 reference

27 November 2017

Roger N Pearse

2

1 reference

27 November 2017

Cherie L Johnson

series ordinal

3

1 reference

27 November 2017

Yongwon Choi

series ordinal

5

1 reference

27 November 2017

Joshua Epstein

series ordinal

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

British Journal of Haematology

27 November 2017

1 reference

27 November 2017

116

1 reference

27 November 2017

278-290

1 reference

27 November 2017

2

1 reference

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Inhibition of tooth eruption in the rat by a bisphosphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

Characterization of bone marrow stromal cells from multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03257.X

10.1046/J.1365-2141.2002.03257.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference